Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02909387 · ClinicalTrials.gov registry record · NA
Adapting Project UPLIFT for Blacks in Georgia
A NA study of Epilepsy and Depressive Symptoms, sponsored by Morehouse School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
- 1
- Study location
NCT02909387: Completed NA study of Epilepsy and Depressive Symptoms, sponsored by Morehouse School of Medicine.
NCT02909387 is a NA study of Epilepsy and Depressive Symptoms that has completed, run by Morehouse School of Medicine. The registered enrollment target is 82 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02909387, a NA study of Epilepsy and Depressive Symptoms, has completed, sponsored by Morehouse School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the efficacy of Project UPLIFT for reducing symptoms of depression and anxiety among African Americans at immediate posttest and after 3 months.
Primary Outcome
Measure of depressive symptoms over previous two weeks.
Conditions Studied
Interventions
- BEHAVIORAL Project UPLIFT
Study Locations (1)
Georgia
- Morehouse School of Medicine - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2016-09-08 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
What the finished NCT02909387 record still lists
NCT02909387 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (91% lower).
The record links to 3 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Project UPLIFT is the first listed.
NCT02909387 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT02909387 about?
NCT02909387 is a clinical study titled "Adapting Project UPLIFT for Blacks in Georgia". Evaluate the efficacy of Project UPLIFT for reducing symptoms of depression and anxiety among African Americans at immediate posttest and after 3 months.
What is the current status of trial NCT02909387?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2016-09-08. Estimated completion is 2019-09-30.
What conditions does trial NCT02909387 study?
This clinical trial studies the following conditions: Epilepsy, Depressive Symptoms, Anxiety Disorders and Symptoms.
What interventions are being tested in trial NCT02909387?
The interventions under investigation include: Project UPLIFT (BEHAVIORAL).
Who is sponsoring clinical trial NCT02909387?
This trial is sponsored by Morehouse School of Medicine, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02909387 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02909387's enrollment target sits among peer trials
82 66th of 160 higher than 95 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SeizEAR Safety Study
RECRUITING · NA
-
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
RECRUITING · NA
-
Subcortical Arousal in Perceptual Awareness
RECRUITING · NA
-
Prediction of Anxiety and Memory State
RECRUITING · NA
-
Implementation and Cost Evaluation of Project UPLIFT
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI